Skip to main content
. 2011 Mar 17;11:167. doi: 10.1186/1471-2458-11-167

Figure 2.

Figure 2

Proportion with a clinically significant (50%) reduction in depressive symptom score. Note: Proportion with a clinically significant reduction in SCL-D depression scores from baseline to follow-up between experimental (Step Up) and usual care (UC) controls: 54% vs. 26%, OR = 3.35, 95% CI [1.01- 12.10], p = 0.05 at 4 months and 52% vs. 13%, OR = 7.27, 95% CI [1.85 - 37.30], p = 0.004 at 6 months.

HHS Vulnerability Disclosure